ENEMEEZ- docusate sodium liquid 
Enemeez LLC DBA Summit Pharmaceuticals

----------

ENEMEEZ ® MINI ENEMA 5ml Disposable Tubes

Drug Facts

Active ingredient (per delivered dose)

Docusate Sodium USP 283 mg

Purpose

Stool Softener Laxative

Uses

Warnings

For rectal use only. Drug Interaction Precaution: Do not take this product if you are presently taking mineral oil, unless directed by a doctor.

Do not use

Stop use and ask a doctor if you have:

Pregnant or Lactating Women, ask a healthcare professional before use.

Keep out of reach of children. In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

Directions

Adults and children 12 years of age and older (with adult supervision) one to three units daily. Children under 12 years of age, consult a doctor prior to use.

Place a few drops of the tube's liquid content on the shaft prior to insertion.

Also apply liquid content or lubricant to the anus before inserting the mini-enema.

Alternate positions: Administer while seated on the toilet. Or, kneel, then lower head and chest forward until side of face is resting on the surface.

Other Information

Other Information Store at room temperature 15°-30° C (59°-86° F)

Inactive Ingredients

Glycerin USP and Polyethylene Glycol

Questions or Comments:

(888) 273-9734 or www.enemeez.com

Manufactured by:

Summit Pharmaceuticals, Inc.

Phoenix, AZ 85027

Distributed by:

Alliance Labs, LLC.

Phoenix, AZ 85027

Principal Display Panels:

9876-5

30count

ENEMEEZ 
docusate sodium liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:17433-9876
Route of AdministrationRECTAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM283 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
POLYETHYLENE GLYCOL 300 (UNII: 5655G9Y8AQ)  
GLYCERIN (UNII: PDC6A3C0OX)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:17433-9876-330 in 1 CONTAINER06/15/2012
1NDC:17433-9876-05 mL in 1 TUBE; Type 0: Not a Combination Product
2NDC:17433-9876-935 in 1 CONTAINER10/08/2021
2NDC:17433-9876-05 mL in 1 TUBE; Type 0: Not a Combination Product
3NDC:17433-9876-55 in 1 CONTAINER01/14/2022
3NDC:17433-9876-05 mL in 1 TUBE; Type 0: Not a Combination Product
4NDC:17433-9876-66 in 1 CONTAINER09/14/202302/23/2024
4NDC:17433-9876-05 mL in 1 TUBE; Type 0: Not a Combination Product
5NDC:17433-9876-22 in 1 CONTAINER01/26/2024
5NDC:17433-9876-05 mL in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00706/15/2012
Labeler - Enemeez LLC DBA Summit Pharmaceuticals (010717819)
Registrant - Enemeez LLC DBA Summit Pharmaceuticals (010717819)
Establishment
NameAddressID/FEIBusiness Operations
Enemeez LLC DBA Summit Pharmaceuticals010717819manufacture(17433-9876)

Revised: 2/2024
Document Id: 12134d63-75fa-02ea-e063-6294a90a7f25
Set id: 0b06445d-0839-497e-bdff-e0fe224a7738
Version: 15
Effective Time: 20240223
 
Enemeez LLC DBA Summit Pharmaceuticals